Skip to content

A double-blind, randomized, controlled, multicenter clinical study of Jinhong Decoction in the treatment of sepsis based on the innovative strategy of

A double-blind, randomized, controlled, multicenter clinical study of Jinhong Decoction in the treatment of sepsis based on the innovative strategy of

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003620
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Sponsors

Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The age of onset was between 18 and 80 years old; 2. The diagnostic criteria of 2016 international guidelines for severe sepsis and septic shock were met; 3. APACHE II score < 30; 4. They voluntarily participated in the experiment and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with allergy to traditional Chinese medicine and allergic constitution; 2. Patients with malignant tumor, liver cirrhosis, chronic renal failure (uremic stage), hematological diseases, HIV and other serious basic diseases were complicated; 3. Long term use of hormone, immunosuppressant and other drug treatment of patients; 4. Those who suffered from serious mental illness or were unable to cooperate with the trial; 5. Those who have participated in other clinical trials at the same time or within 30 days; 6. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Mortality;

Secondary

MeasureTime frame
C-reactive protein;interleukin-10;kidney function;blood routine;tumor necrosis factor (TNF-a);procalcitonin;superoxide dismutase;species and quantity of intestinal microorganisms;coagulation function;liver function;troponin;procalcitonin;interleukin-6;SOFA score;TCM syndrome score;BNP;fecal routine;myocardial enzyme spectrum;

Countries

China

Contacts

Public ContactFang Bangjiang

Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine

fangbji@163.com+86 18917763257

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026